• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.

作者信息

Nachbaur K, Dietze O, Herold M, Thaler J, Braunsteiner H, Vogel W

出版信息

Eur J Haematol. 1992 Oct;49(4):221-3. doi: 10.1111/j.1600-0609.1992.tb00052.x.

DOI:10.1111/j.1600-0609.1992.tb00052.x
PMID:1464366
Abstract
摘要

相似文献

1
Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.高剂量阿糖胞苷和米托蒽醌治疗急性髓性白血病复发后出现暴发性肝衰竭。
Eur J Haematol. 1992 Oct;49(4):221-3. doi: 10.1111/j.1600-0609.1992.tb00052.x.
2
High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia.大剂量阿糖胞苷与米托蒽醌：难治性急性髓系白血病的一种高效治疗方案。
Blood. 1987 Mar;69(3):744-9.
3
Pharmacokinetic study of cytosine arabinoside in patients with acute myelogeneous leukemia.急性髓细胞白血病患者阿糖胞苷的药代动力学研究
Haematol Blood Transfus. 1987;30:288-92. doi: 10.1007/978-3-642-71213-5_43.
4
High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.大剂量阿糖胞苷联合米托蒽醌治疗难治性急性髓系白血病和急性淋巴细胞白血病
Semin Oncol. 1987 Jun;14(2 Suppl 1):73-7.
5
[Combined therapy with mitoxantrone and cytosine arabinoside as a first-line treatment in ANLL: preliminary results].[米托蒽醌与阿糖胞苷联合治疗作为急性非淋巴细胞白血病一线治疗的初步结果]
Sangre (Barc). 1993 Jun;38(3):250-1.
6
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).将复发和难治性急性髓细胞白血病分类的提议，作为对序贯应用大剂量与中剂量阿糖胞苷联合米托蒽醌（S-HAM）进行年龄调整随机比较的基础。
Haematol Blood Transfus. 1990;33:604-10. doi: 10.1007/978-3-642-74643-7_110.
7
[A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2011 Dec;32(12):869-70.
8
Intensive consolidation chemotherapy for newly diagnosed acute myeloid leukemia using a regime containing moderate dose cytosine arabinoside and mitoxantrone.使用包含中等剂量阿糖胞苷和米托蒽醌的方案对新诊断的急性髓性白血病进行强化巩固化疗。
Anticancer Drugs. 1995 Apr;6(2):224-8. doi: 10.1097/00001813-199504000-00005.
9
Reversible bilateral lateral rectus muscle palsy associated with high-dose cytosine arabinoside and mitoxantrone therapy.与大剂量阿糖胞苷和米托蒽醌治疗相关的可逆性双侧外直肌麻痹
Cancer. 1986 Oct 15;58(8):1633-5. doi: 10.1002/1097-0142(19861015)58:8<1633::aid-cncr2820580809>3.0.co;2-a.
10
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML).一项关于阿沃西地布、阿糖胞苷和米托蒽醌对比阿糖胞苷和柔红霉素（7+3）用于新诊断高危急性髓系白血病（AML）的随机多中心II期研究的最终结果。
Leuk Res. 2018 Sep;72:92-95. doi: 10.1016/j.leukres.2018.08.005. Epub 2018 Aug 10.

引用本文的文献

1
Acute Hepatotoxicity After High-Dose Cytarabine for the Treatment of Relapsed Acute Myeloid Leukemia: A Case Report.大剂量阿糖胞苷治疗复发急性髓系白血病后的急性肝毒性：一例报告
Hosp Pharm. 2019 Jun;54(3):160-164. doi: 10.1177/0018578718779763. Epub 2018 Jun 1.
2
Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.阿糖胞苷与双嘧达莫可能相互作用导致的肝毒性：一例报告
Eur J Clin Pharmacol. 2004 Aug;60(6):455-6. doi: 10.1007/s00228-004-0790-8. Epub 2004 Jul 1.